Sobi to present clinical data on Gamifant® at Histiocyte Society 2026 in Rotterdam

ConferenceGamifantNeutral

AI Analysis

Summary

Sobi announced that new clinical data on Gamifant (emapalumab) for primary haemophagocytic lymphohistiocytosis will be presented at the 2026 Annual Meeting of the Histiocyte Society on September 26-29, 2026 in Rotterdam.

Importance:4/10

Sentiment:

0.00

data presentationconferenceGamifantHLH

Related Companies

$SOBI

Read the original article

Published by PR Newswire Biotech on September 24, 2026 8:53 AM

Read Original